GeneDx Holdings Corp. (WGS): A Bull Case Theory [Yahoo! Finance]
GeneDx Holdings Corp. - Class A (WGS)
Company Research
Source: Yahoo! Finance
GeneDx Holdings Corp.'s share was trading at $92.04 as of February 18th. WGS's trailing and forward P/E were 819.55 and 77.52 respectively according to Yahoo Finance. create jobs 51/Shutterstock.com GeneDx is emerging as a high-growth genomics diagnostics company with a differentiated clinical dataset and proprietary interpretation IP that supports strong diagnostic yield, particularly in rare-disease exome and genome testing. The business benefits from structural resilience, as healthcare spending is large and relatively insulated from broader economic cycles, while regulatory tailwinds—most recently the FDA's Breakthrough Device designation for ExomeDx™ and GenomeDx™ tests—accelerate payer engagement and adoption. Q3 2025 results underscore strong fundamentals, with revenue of $116.7 million, roughly 65% year-over-year growth in exome/genome test revenue, and adjusted net income of ~$14.7 million, reflecting several consecutive quarters of improving profitability and operating
Show less
Read more
Impact Snapshot
Event Time:
WGS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WGS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WGS alerts
High impacting GeneDx Holdings Corp. - Class A news events
Weekly update
A roundup of the hottest topics
WGS
News
- Down 25% in 4 Weeks, Here's Why GENEDX HOLDINGS (WGS) Looks Ripe for a Turnaround [Yahoo! Finance]Yahoo! Finance
- GeneDx's Chief Operating Officer Sold Nearly 6,000 Shares. Is the Stock a Buy or Sell? [Yahoo! Finance]Yahoo! Finance
- GeneDx (WGS) was upgraded by Zacks Research from "hold" to "strong-buy".MarketBeat
- HALPER SADEH LLC ENCOURAGES GENEDX HOLDINGS CORP. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTSPR Newswire
- GeneDx to Participate in Upcoming Investor ConferencesBusiness Wire
WGS
Earnings
- 2/23/26 - Beat
WGS
Sec Filings
- 3/5/26 - Form 4
- 3/5/26 - Form 4
- 3/5/26 - Form 4
- WGS's page on the SEC website